Synexus currently seeking people with psoriasis in Glasgow to help
Synexus, the world's largest multinational company dedicated to the successful recruitment and running of clinical studies, is currently recruiting patients in Glasgow for a study which is assessing a new treatment which may help ease the symptoms of psoriasis.
Psoriasis is a skin condition that causes red, flaky, crusty patches of skin covered with silvery scales. The condition is not infectious and most people are affected only in small patches on their body. It affects around 2% of people in the UK. It can start at any age, but most often develops between the ages of 11 and 45. The severity of psoriasis varies greatly from person to person. For some people it is just a minor irritation, but for others it has a major impact on their quality of life.
There is currently no cure for psoriasis. However, there are various treatments that can help control the symptoms.
The study that Synexus is running is assessing a topical ointment that may help ease the symptoms of psoriasis.
The study may be suitable for those who:
• Are aged over 18 years old
• Have been diagnosed with psoriasis
Synexus is currently recruiting patients for this study at its Dedicated Clinical Research Centre in Glasgow. Those who would like to find out more or are interested in participating in this study should contact their nearest centre and quote the relevant reference number:
• Scotland: 0141 2702587 (Ref: code 6560)
There is no obligation for people to participate and if they do decide to take part, their GP will be kept fully informed of their involvement. Patients will be reimbursed for their time and all reasonable out of pocket expenses if they are accepted onto the study.
Synexus has many years experience in conducting a wide range of clinical studies. The purpose of a clinical research study is to answer important questions about a new medicine, for example: does it improve a person’s health and which dose of the medicine works best?
Each year, thousands of patients take part in clinical studies at Synexus’ Dedicated Clinical Research Centres. There are many different studies running at each of the Centres throughout the year including potential treatments for conditions such as osteoporosis, smoking cessation, high-cholesterol, insomnia, vaccines, asthma and childhood eczema.
Participating in a Synexus clinical study means patients receive increased medical attention and may benefit from medications that aren’t yet available to other sufferers of their condition, while making a positive contribution to the health of future generations.
For more information about Synexus and the other studies that it is currently conducting visit www.improvinghealth.com
- ENDS -
Notes to Editors:
https://www.psoriasis-association.org.uk o http://www.nhs.uk/Conditions/Psoriasis/Pages/Introduction.aspx
• Synexus is the world’s largest multi-national company dedicated to the recruitment and running of clinical trials.
• More information can be found at www.improvinghealth.com / www.improvinghealthtogether.com / www.synexus.com